SOPHiA GENETICS (SOPH) Current Assets (2020 - 2025)

SOPHiA GENETICS (SOPH) has 6 years of Current Assets data on file, last reported at $99.1 million in Q4 2025.

• For the quarter ending Q4 2025, Current Assets changed 0.33% year-over-year to $99.1 million; the trailing twelve-month figure through Dec 2025 stood at $99.1 million (changed 0.33% YoY), and the FY2025 full-year result was $99.1 million, changed 0.33% from the prior year.
• Current Assets fell to $99.1 million in Q4 2025, from $103.5 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $300.8 million in Q3 2021 to a low of $80.2 million in Q2 2021.
• A 5-year average of $162.7 million and a median of $148.0 million in 2023 frame the typical range for Current Assets.
• Across the five-year window, Current Assets surged 192.35% in 2022 and slumped 32.86% in 2024, its largest moves.
• Tracing SOPH's Current Assets over 5 years: stood at $282.9 million in 2021, then plunged by 30.62% to $196.3 million in 2022, then dropped by 24.56% to $148.0 million in 2023, then tumbled by 32.86% to $99.4 million in 2024, then declined by 0.33% to $99.1 million in 2025.
• Business Quant data shows SOPH's Current Assets at $99.1 million in Q4 2025, $103.5 million in Q3 2025, and $117.0 million in Q2 2025.